Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #17567 on Ariad Pharmaceuticals Inc fka ARIA
DewDiligence
03/25/12 8:35 PM
#17568 RE: mejs #17567
Gilead Sciences bags Pharmasset's hep C pipeline in $11B buyout. We will see a huge premium. IMHO $100 a share.